Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics

Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on non-pharmaceutical interventions, such as social distancing, teleworking, mouth masks and contact tracing. However, as pre-symptomatic transmis...

Full description

Saved in:
Bibliographic Details
Published inPLoS computational biology Vol. 17; no. 3; p. e1008688
Main Authors Libin, Pieter J K, Willem, Lander, Verstraeten, Timothy, Torneri, Andrea, Vanderlocht, Joris, Hens, Niel
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 09.03.2021
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on non-pharmaceutical interventions, such as social distancing, teleworking, mouth masks and contact tracing. However, as pre-symptomatic transmission remains an important driver of the epidemic, contact tracing efforts struggle to fully control SARS-CoV-2 epidemics. Therefore, in this work, we investigate to what extent the use of universal testing, i.e., an approach in which we screen the entire population, can be utilized to mitigate this epidemic. To this end, we rely on PCR test pooling of individuals that belong to the same households, to allow for a universal testing procedure that is feasible with the limited testing capacity. We evaluate two isolation strategies: on the one hand pool isolation, where we isolate all individuals that belong to a positive PCR test pool, and on the other hand individual isolation, where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step. We evaluate this universal testing approach in the STRIDE individual-based epidemiological model in the context of the Belgian COVID-19 epidemic. As the organisation of universal testing will be challenging, we discuss the different aspects related to sample extraction and PCR testing, to demonstrate the feasibility of universal testing when a decentralized testing approach is used. We show through simulation, that weekly universal testing is able to control the epidemic, even when many of the contact reductions are relieved. Finally, our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus.
AbstractList Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on non-pharmaceutical interventions, such as social distancing, teleworking, mouth masks and contact tracing. However, as pre-symptomatic transmission remains an important driver of the epidemic, contact tracing efforts struggle to fully control SARS-CoV-2 epidemics. Therefore, in this work, we investigate to what extent the use of universal testing, i.e., an approach in which we screen the entire population, can be utilized to mitigate this epidemic. To this end, we rely on PCR test pooling of individuals that belong to the same households, to allow for a universal testing procedure that is feasible with the limited testing capacity. We evaluate two isolation strategies: on the one hand pool isolation, where we isolate all individuals that belong to a positive PCR test pool, and on the other hand individual isolation, where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step. We evaluate this universal testing approach in the STRIDE individual-based epidemiological model in the context of the Belgian COVID-19 epidemic. As the organisation of universal testing will be challenging, we discuss the different aspects related to sample extraction and PCR testing, to demonstrate the feasibility of universal testing when a decentralized testing approach is used. We show through simulation, that weekly universal testing is able to control the epidemic, even when many of the contact reductions are relieved. Finally, our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus.
[...]our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus. [...]the large amount of PCR tests that is required to facilitate this approach, remains an important impediment. [...]we propose a new universal testing procedure that is feasible with the current testing capacity, where we rely on PCR test pooling of individuals that belong to the same households. [...]pool isolation, where we isolate all individuals that belong to a positive PCR test pool, regardless of their individual infection status. [...]individual isolation, where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step.
Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on non-pharmaceutical interventions, such as social distancing, teleworking, mouth masks and contact tracing. However, as pre-symptomatic transmission remains an important driver of the epidemic, contact tracing efforts struggle to fully control SARS-CoV-2 epidemics. Therefore, in this work, we investigate to what extent the use of universal testing, i.e., an approach in which we screen the entire population, can be utilized to mitigate this epidemic. To this end, we rely on PCR test pooling of individuals that belong to the same households, to allow for a universal testing procedure that is feasible with the limited testing capacity. We evaluate two isolation strategies: on the one hand pool isolation , where we isolate all individuals that belong to a positive PCR test pool, and on the other hand individual isolation , where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step. We evaluate this universal testing approach in the STRIDE individual-based epidemiological model in the context of the Belgian COVID-19 epidemic. As the organisation of universal testing will be challenging, we discuss the different aspects related to sample extraction and PCR testing, to demonstrate the feasibility of universal testing when a decentralized testing approach is used. We show through simulation, that weekly universal testing is able to control the epidemic, even when many of the contact reductions are relieved. Finally, our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus.
[...]our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus. [...]the large amount of PCR tests that is required to facilitate this approach, remains an important impediment. [...]we propose a new universal testing procedure that is feasible with the current testing capacity, where we rely on PCR test pooling of individuals that belong to the same households. [...]pool isolation, where we isolate all individuals that belong to a positive PCR test pool, regardless of their individual infection status. [...]individual isolation, where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step.
Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on non-pharmaceutical interventions, such as social distancing, teleworking, mouth masks and contact tracing. However, as pre-symptomatic transmission remains an important driver of the epidemic, contact tracing efforts struggle to fully control SARS-CoV-2 epidemics. Therefore, in this work, we investigate to what extent the use of universal testing, i.e., an approach in which we screen the entire population, can be utilized to mitigate this epidemic. To this end, we rely on PCR test pooling of individuals that belong to the same households, to allow for a universal testing procedure that is feasible with the limited testing capacity. We evaluate two isolation strategies: on the one hand pool isolation , where we isolate all individuals that belong to a positive PCR test pool, and on the other hand individual isolation , where we determine which of the individuals that belong to the positive PCR pool are positive, through an additional testing step. We evaluate this universal testing approach in the STRIDE individual-based epidemiological model in the context of the Belgian COVID-19 epidemic. As the organisation of universal testing will be challenging, we discuss the different aspects related to sample extraction and PCR testing, to demonstrate the feasibility of universal testing when a decentralized testing approach is used. We show through simulation, that weekly universal testing is able to control the epidemic, even when many of the contact reductions are relieved. Finally, our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the virus. As pre-symptomatic transmission is an important driver of COVID-19 epidemics (i.e., the virus is transmitted before the infected individual is aware of its infection), contact tracing efforts struggle to fully control SARS-CoV-2 epidemics. For this reason, the use of universal testing, where each individual of the community is tested on a regular basis, has been suggested. However, the large amount of PCR tests that is required to facilitate this approach, remains an important impediment. Therefore, we propose a new universal testing procedure that is feasible with the current testing capacity, where we rely on PCR test pooling of individuals that belong to the same households. We evaluate this universal testing procedure in a fine-grained epidemiological model (i.e., an individual-based model) that covers the Belgian population. Through this evaluation, we assess the procedure’s performance to keep the epidemic under control, while allowing for various contact reductions. We assess the robustness of the model, by analysing different levels of community compliance, and we show that weekly universal testing could prove a successful strategy to control SARS-CoV-2 outbreaks.
Audience Academic
Author Libin, Pieter J K
Vanderlocht, Joris
Hens, Niel
Willem, Lander
Torneri, Andrea
Verstraeten, Timothy
AuthorAffiliation University of Notre Dame, UNITED STATES
3 KU Leuven – University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium
4 Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
2 Artificial Intelligence Lab, Department of computer science, Vrije Universiteit Brussel, Brussels, Belgium
1 Interuniversity Institute of Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium
AuthorAffiliation_xml – name: 3 KU Leuven – University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium
– name: 2 Artificial Intelligence Lab, Department of computer science, Vrije Universiteit Brussel, Brussels, Belgium
– name: 1 Interuniversity Institute of Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium
– name: 4 Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
– name: University of Notre Dame, UNITED STATES
Author_xml – sequence: 1
  givenname: Pieter J K
  orcidid: 0000-0003-3906-758X
  surname: Libin
  fullname: Libin, Pieter J K
  organization: KU Leuven - University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium
– sequence: 2
  givenname: Lander
  orcidid: 0000-0002-9210-1196
  surname: Willem
  fullname: Willem, Lander
  organization: Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
– sequence: 3
  givenname: Timothy
  orcidid: 0000-0003-3036-617X
  surname: Verstraeten
  fullname: Verstraeten, Timothy
  organization: Artificial Intelligence Lab, Department of computer science, Vrije Universiteit Brussel, Brussels, Belgium
– sequence: 4
  givenname: Andrea
  orcidid: 0000-0002-4322-0770
  surname: Torneri
  fullname: Torneri, Andrea
  organization: Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
– sequence: 5
  givenname: Joris
  orcidid: 0000-0003-1635-2791
  surname: Vanderlocht
  fullname: Vanderlocht, Joris
  organization: Interuniversity Institute of Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium
– sequence: 6
  givenname: Niel
  orcidid: 0000-0003-1881-0637
  surname: Hens
  fullname: Hens, Niel
  organization: Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33690626$$D View this record in MEDLINE/PubMed
BookMark eNqVkk2P2yAQhq1qq-5H-w-qFqmX9uDUGIzxpVKUfkVadaV-XRGGwSEikDX2qvvvSxLvalPtpeIAgmfeYd6Z8-zEBw9Z9hIXM0xq_H4dxt5LN9uq1s5wUXDG-ZPsDFcVyWtS8ZMH59PsPMZ1UaRjw55lp4SwpmAlO8vCPEaI0foODStABmS0rXV2uEXSawTGgBrsDfgEoWDQKowRVsHpfBuCA41Gn177KB0aIA57nYBU8EMfHFpc_V5-zHGDYGs1bKyKz7OnRroIL6b9Ivv1-dPPxdf88urLcjG_zBVjeMhJi6EuDZS0bduSUlwXgHXBGt6YqlAy7VS3ktTQAmu0IRoTzEvAppKKtCW5yF4fdLcuRDF5FUVZYcI4xRVPxPJA6CDXYtvbjexvRZBW7C9C3wnZD1Y5ELjRJaMKGqkbiiVveG24JopWXKXkO60PU7ax3YBWkMqX7kj0-MXblejCjagbSlJbksDbSaAP12MyUmxsVOCc9JAcT_9OFOeY4oS--Qd9vLqJ6mQqwHoTUl61ExVzVvEal4zRRM0eodLaNyvNm7Hp_ijg3VHArtHwZ-jkGKNY_vj-H-y3Y5YeWNWHGHsw997hQuzG_a5IsRt3MY17Cnv10Pf7oLv5Jn8BMon96A
CitedBy_id crossref_primary_10_7554_eLife_75593
crossref_primary_10_1016_j_eswa_2024_123686
crossref_primary_10_1016_j_mbs_2022_108805
crossref_primary_10_1038_s41598_021_01065_0
crossref_primary_10_1186_s12879_021_06092_w
crossref_primary_10_1080_21655979_2021_1987821
crossref_primary_10_22207_JPAM_16_4_11
crossref_primary_10_1038_s41598_022_10128_9
crossref_primary_10_1098_rsif_2023_0087
crossref_primary_10_1016_j_jtbi_2023_111703
crossref_primary_10_1371_journal_pcbi_1009980
crossref_primary_10_1371_journal_pcbi_1008892
crossref_primary_10_1186_s12879_024_09007_7
crossref_primary_10_3389_fpubh_2022_757065
crossref_primary_10_3390_tropicalmed7110376
crossref_primary_10_1021_jacsau_1c00048
crossref_primary_10_3389_fmicb_2022_889643
crossref_primary_10_1016_j_epidem_2023_100701
crossref_primary_10_1371_journal_pcbi_1010008
crossref_primary_10_2196_44349
Cites_doi 10.1101/2020.06.08.20125179
10.1101/2020.04.23.20077024
10.1098/rspb.2010.2688
10.1073/pnas.1911083116
10.1038/d41573-020-00016-0
10.1101/2020.07.18.20156307
10.1101/2020.02.08.20021162
10.1038/s41591-020-1036-8
10.1186/s12916-020-01636-4
10.1001/jama.2020.12603
10.1016/S0140-6736(20)30936-3
10.1016/S0140-6736(20)32261-3
10.1016/j.hrthm.2020.06.026
10.1137/0207001
10.1101/2020.06.22.20136309
10.1038/s41591-020-0869-5
10.1016/S1473-3099(20)30457-6
10.1038/s41591-020-0822-7
10.1101/2020.03.26.20039438
10.1101/2020.08.04.20167874
10.1371/journal.pone.0048695
10.1101/2020.06.29.20142851
10.1016/j.procs.2017.05.086
10.1371/journal.pone.0243692
10.1016/j.vaccine.2019.06.081
10.1016/S2213-2600(20)30222-8
10.1126/science.abb4218
10.1038/s41591-020-0962-9
10.2807/1560-7917.ES.2020.25.5.2000062
10.1056/NEJMp2005630
10.1126/sciadv.abd3083
10.1101/2020.04.27.20078329
10.1093/bib/bbaa232
10.1126/science.abc5798
ContentType Journal Article
Copyright COPYRIGHT 2021 Public Library of Science
2021 Libin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 Libin et al 2021 Libin et al
Copyright_xml – notice: COPYRIGHT 2021 Public Library of Science
– notice: 2021 Libin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 Libin et al 2021 Libin et al
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ISN
ISR
3V.
7QO
7QP
7TK
7TM
7X7
7XB
88E
8AL
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
CCPQU
COVID
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
JQ2
K7-
K9.
LK8
M0N
M0S
M1P
M7P
P5Z
P62
P64
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pcbi.1008688
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Gale In Context: Canada
Gale in Context: Science
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Computing Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Computer Science Collection
Computer Science Database
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Computing Database
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
Computer Science Database
ProQuest Central Student
Technology Collection
Technology Research Database
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest Computer Science Collection
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Genetics Abstracts
Health Research Premium Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Computing
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Computing (Alumni Edition)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Advanced Technologies & Aerospace Database
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic

CrossRef
Publicly Available Content Database
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Household-pooled universal testing to control COVID-19 epidemics
EISSN 1553-7358
Editor Perkins, Alex
Editor_xml – sequence: 1
  givenname: Alex
  surname: Perkins
  fullname: Perkins, Alex
EndPage e1008688
ExternalDocumentID 2513684158
oai_doaj_org_article_19d264ce9ad941a8987f8d3c458c9df8
A658712664
10_1371_journal_pcbi_1008688
33690626
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Belgium
GeographicLocations_xml – name: Belgium
GrantInformation_xml – fundername: European Research Council
GroupedDBID ---
123
29O
2WC
3V.
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
AAFWJ
AAKPC
ABDBF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ARAPS
AZQEC
B0M
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
BWKFM
C1A
CCPQU
CGR
CS3
CUY
CVF
DIK
DWQXO
E3Z
EAP
EAS
EBD
EBS
ECM
EIF
EJD
EMK
EMOBN
ESX
F5P
FPL
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IGS
INH
INR
IPNFZ
ISN
ISR
ITC
J9A
K6V
K7-
KQ8
LK8
M0N
M1P
M48
M7P
M~E
NPM
O5R
O5S
OK1
P2P
P62
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PV9
RIG
RNS
RPM
RZL
SV3
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
AAYXX
AFPKN
CITATION
7QO
7QP
7TK
7TM
7XB
8AL
8FD
8FK
COVID
FR3
JQ2
K9.
P64
PQEST
PQUKI
PRINS
Q9U
RC3
7X8
5PM
-
AAPBV
ABPTK
ADACO
BBAFP
ID FETCH-LOGICAL-c661t-3b1e72fe24bbb244170e1d06989f50ca9894dba37ebe69df3d13182e1f5ac3b23
IEDL.DBID RPM
ISSN 1553-7358
1553-734X
IngestDate Fri Nov 26 17:11:57 EST 2021
Tue Oct 22 15:13:08 EDT 2024
Tue Sep 17 21:21:55 EDT 2024
Fri Oct 25 05:52:10 EDT 2024
Thu Oct 10 19:12:47 EDT 2024
Fri Feb 23 00:13:24 EST 2024
Fri Oct 18 02:35:25 EDT 2024
Thu Aug 01 19:27:19 EDT 2024
Fri Oct 18 02:33:28 EDT 2024
Fri Aug 23 00:47:43 EDT 2024
Wed Oct 16 00:43:38 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c661t-3b1e72fe24bbb244170e1d06989f50ca9894dba37ebe69df3d13182e1f5ac3b23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The authors have read the journal’s policy concerning competing interests. JV is, besides his employment at the Hasselt University, part of the investment team of Bioqube Ventures. Bioqube Ventures was not involved in this work, nor does it prosper financially as a result of the current study. The other authors declare that they have no competing interests.
ORCID 0000-0002-9210-1196
0000-0003-1635-2791
0000-0002-4322-0770
0000-0003-1881-0637
0000-0003-3036-617X
0000-0003-3906-758X
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943003/
PMID 33690626
PQID 2513684158
PQPubID 1436340
ParticipantIDs plos_journals_2513684158
doaj_primary_oai_doaj_org_article_19d264ce9ad941a8987f8d3c458c9df8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7943003
proquest_miscellaneous_2500388141
proquest_journals_2513684158
gale_infotracmisc_A658712664
gale_infotracacademiconefile_A658712664
gale_incontextgauss_ISR_A658712664
gale_incontextgauss_ISN_A658712664
crossref_primary_10_1371_journal_pcbi_1008688
pubmed_primary_33690626
PublicationCentury 2000
PublicationDate 2021-03-09
PublicationDateYYYYMMDD 2021-03-09
PublicationDate_xml – month: 03
  year: 2021
  text: 2021-03-09
  day: 09
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PLoS computational biology
PublicationTitleAlternate PLoS Comput Biol
PublicationYear 2021
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References I Baptista (pcbi.1008688.ref048) 2019; 93
pcbi.1008688.ref033
Q Li (pcbi.1008688.ref034) 2020
P Spagnolo (pcbi.1008688.ref012) 2020; 8
A Torneri (pcbi.1008688.ref014) 2020; 18
EG Coffman (pcbi.1008688.ref026) 1978; 7
LM Kucirka (pcbi.1008688.ref039) 2020
JT Wu (pcbi.1008688.ref035) 2020; 26
E Lavezzo (pcbi.1008688.ref019) 2020
L Willem (pcbi.1008688.ref041) 2012; 7
pcbi.1008688.ref032
pcbi.1008688.ref027
A Sakurai (pcbi.1008688.ref002) 2020
pcbi.1008688.ref029
pcbi.1008688.ref028
pcbi.1008688.ref023
pcbi.1008688.ref022
NG Davies (pcbi.1008688.ref036) 2020; 26
AJ Kucharski (pcbi.1008688.ref037) 2020; 20
S Woloshin (pcbi.1008688.ref042) 2020
X He (pcbi.1008688.ref031) 2020; 26
pcbi.1008688.ref020
pcbi.1008688.ref016
pcbi.1008688.ref015
pcbi.1008688.ref018
pcbi.1008688.ref011
S Ozawa (pcbi.1008688.ref049) 2019; 37
pcbi.1008688.ref013
E Holt (pcbi.1008688.ref051) 2020; 396
JA Firth (pcbi.1008688.ref038) 2020; 26
pcbi.1008688.ref010
pcbi.1008688.ref053
L Willem (pcbi.1008688.ref021) 2020
pcbi.1008688.ref050
pcbi.1008688.ref005
pcbi.1008688.ref004
pcbi.1008688.ref007
pcbi.1008688.ref001
pcbi.1008688.ref045
pcbi.1008688.ref044
pcbi.1008688.ref047
pcbi.1008688.ref046
J Peto (pcbi.1008688.ref017) 2020; 368
S Nickbakhsh (pcbi.1008688.ref024) 2019; 116
pcbi.1008688.ref009
pcbi.1008688.ref008
T House (pcbi.1008688.ref025) 2011; 278
MU Kraemer (pcbi.1008688.ref006) 2020; 368
N Lurie (pcbi.1008688.ref003) 2020; 382
pcbi.1008688.ref040
JA Backer (pcbi.1008688.ref030) 2020; 25
pcbi.1008688.ref043
EP Fischer (pcbi.1008688.ref052) 2020
References_xml – year: 2020
  ident: pcbi.1008688.ref021
  article-title: The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19: an individual-based modelling study
  publication-title: Nature Communications
  contributor:
    fullname: L Willem
– ident: pcbi.1008688.ref033
  doi: 10.1101/2020.06.08.20125179
– ident: pcbi.1008688.ref007
– ident: pcbi.1008688.ref015
  doi: 10.1101/2020.04.23.20077024
– volume: 278
  start-page: 2753
  issue: 1719
  year: 2011
  ident: pcbi.1008688.ref025
  article-title: Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic
  publication-title: Proceedings of the Royal Society B: Biological Sciences
  doi: 10.1098/rspb.2010.2688
  contributor:
    fullname: T House
– ident: pcbi.1008688.ref023
– volume: 116
  start-page: 27142
  issue: 52
  year: 2019
  ident: pcbi.1008688.ref024
  article-title: Virus–virus interactions impact the population dynamics of influenza and the common cold
  publication-title: Proceedings of the National Academy of Sciences
  doi: 10.1073/pnas.1911083116
  contributor:
    fullname: S Nickbakhsh
– volume: 368
  year: 2020
  ident: pcbi.1008688.ref017
  article-title: Covid-19 mass testing facilities could end the epidemic rapidly
  publication-title: BMJ
  contributor:
    fullname: J Peto
– ident: pcbi.1008688.ref004
  doi: 10.1038/d41573-020-00016-0
– ident: pcbi.1008688.ref032
  doi: 10.1101/2020.07.18.20156307
– ident: pcbi.1008688.ref013
  doi: 10.1101/2020.02.08.20021162
– volume: 26
  start-page: 1616
  issue: 10
  year: 2020
  ident: pcbi.1008688.ref038
  article-title: Using a real-world network to model localized COVID-19 control strategies
  publication-title: Nature medicine
  doi: 10.1038/s41591-020-1036-8
  contributor:
    fullname: JA Firth
– volume: 18
  start-page: 191
  issue: 1
  year: 2020
  ident: pcbi.1008688.ref014
  article-title: A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
  publication-title: BMC Medicine
  doi: 10.1186/s12916-020-01636-4
  contributor:
    fullname: A Torneri
– ident: pcbi.1008688.ref010
  doi: 10.1001/jama.2020.12603
– ident: pcbi.1008688.ref016
  doi: 10.1016/S0140-6736(20)30936-3
– ident: pcbi.1008688.ref008
– start-page: 1
  year: 2020
  ident: pcbi.1008688.ref019
  article-title: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’
  publication-title: Nature
  contributor:
    fullname: E Lavezzo
– ident: pcbi.1008688.ref029
– volume: 396
  start-page: 1386
  issue: 10260
  year: 2020
  ident: pcbi.1008688.ref051
  article-title: Slovakia to test all adults for SARS-CoV-2
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(20)32261-3
  contributor:
    fullname: E Holt
– ident: pcbi.1008688.ref022
– ident: pcbi.1008688.ref011
  doi: 10.1016/j.hrthm.2020.06.026
– ident: pcbi.1008688.ref001
– volume: 7
  start-page: 1
  issue: 1
  year: 1978
  ident: pcbi.1008688.ref026
  article-title: An application of bin-packing to multiprocessor scheduling
  publication-title: SIAM Journal on Computing
  doi: 10.1137/0207001
  contributor:
    fullname: EG Coffman
– ident: pcbi.1008688.ref043
  doi: 10.1101/2020.06.22.20136309
– volume: 26
  start-page: 672
  issue: 5
  year: 2020
  ident: pcbi.1008688.ref031
  article-title: Temporal dynamics in viral shedding and transmissibility of COVID-19
  publication-title: Nature Medicine
  doi: 10.1038/s41591-020-0869-5
  contributor:
    fullname: X He
– year: 2020
  ident: pcbi.1008688.ref034
  article-title: Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia
  publication-title: New England Journal of Medicine
  contributor:
    fullname: Q Li
– volume: 20
  start-page: 1151
  issue: 10
  year: 2020
  ident: pcbi.1008688.ref037
  article-title: Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study
  publication-title: The Lancet Infectious Diseases
  doi: 10.1016/S1473-3099(20)30457-6
  contributor:
    fullname: AJ Kucharski
– ident: pcbi.1008688.ref040
– volume: 26
  start-page: 506
  issue: 4
  year: 2020
  ident: pcbi.1008688.ref035
  article-title: Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
  publication-title: Nature Medicine
  doi: 10.1038/s41591-020-0822-7
  contributor:
    fullname: JT Wu
– ident: pcbi.1008688.ref020
  doi: 10.1101/2020.03.26.20039438
– year: 2020
  ident: pcbi.1008688.ref039
  article-title: Variation in false-negative rate of reverse transcriptase polymerase chain reaction–based SARS-CoV-2 tests by time since exposure
  publication-title: Annals of Internal Medicine
  contributor:
    fullname: LM Kucirka
– ident: pcbi.1008688.ref044
– ident: pcbi.1008688.ref009
– ident: pcbi.1008688.ref047
  doi: 10.1101/2020.08.04.20167874
– volume: 7
  start-page: e48695
  issue: 11
  year: 2012
  ident: pcbi.1008688.ref041
  article-title: A nice day for an infection? Weather conditions and social contact patterns relevant to influenza transmission
  publication-title: PloS one
  doi: 10.1371/journal.pone.0048695
  contributor:
    fullname: L Willem
– ident: pcbi.1008688.ref050
– ident: pcbi.1008688.ref028
  doi: 10.1101/2020.06.29.20142851
– ident: pcbi.1008688.ref027
  doi: 10.1016/j.procs.2017.05.086
– ident: pcbi.1008688.ref045
  doi: 10.1371/journal.pone.0243692
– volume: 37
  start-page: 5525
  issue: 37
  year: 2019
  ident: pcbi.1008688.ref049
  article-title: Defining hard-to-reach populations for vaccination
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2019.06.081
  contributor:
    fullname: S Ozawa
– volume: 8
  start-page: 750
  issue: 8
  year: 2020
  ident: pcbi.1008688.ref012
  article-title: Pulmonary fibrosis secondary to COVID-19: a call to arms?
  publication-title: The Lancet Respiratory Medicine
  doi: 10.1016/S2213-2600(20)30222-8
  contributor:
    fullname: P Spagnolo
– ident: pcbi.1008688.ref018
– volume: 368
  start-page: 493
  issue: 6490
  year: 2020
  ident: pcbi.1008688.ref006
  article-title: The effect of human mobility and control measures on the COVID-19 epidemic in China
  publication-title: Science
  doi: 10.1126/science.abb4218
  contributor:
    fullname: MU Kraemer
– volume: 26
  start-page: 1205
  issue: 8
  year: 2020
  ident: pcbi.1008688.ref036
  article-title: Age-dependent effects in the transmission and control of COVID-19 epidemics
  publication-title: Nature Medicine
  doi: 10.1038/s41591-020-0962-9
  contributor:
    fullname: NG Davies
– volume: 25
  start-page: 2000062
  issue: 5
  year: 2020
  ident: pcbi.1008688.ref030
  article-title: Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020
  publication-title: Eurosurveillance
  doi: 10.2807/1560-7917.ES.2020.25.5.2000062
  contributor:
    fullname: JA Backer
– volume: 382
  start-page: 1969
  issue: 21
  year: 2020
  ident: pcbi.1008688.ref003
  article-title: Developing Covid-19 vaccines at pandemic speed
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJMp2005630
  contributor:
    fullname: N Lurie
– start-page: eabd3083
  year: 2020
  ident: pcbi.1008688.ref052
  article-title: Low-cost measurement of facemask efficacy for filtering expelled droplets during speech
  publication-title: Science Advances
  doi: 10.1126/sciadv.abd3083
  contributor:
    fullname: EP Fischer
– ident: pcbi.1008688.ref046
  doi: 10.1101/2020.04.27.20078329
– ident: pcbi.1008688.ref005
  doi: 10.1093/bib/bbaa232
– year: 2020
  ident: pcbi.1008688.ref002
  article-title: Natural History of Asymptomatic SARS-CoV-2 Infection
  publication-title: New England Journal of Medicine
  contributor:
    fullname: A Sakurai
– ident: pcbi.1008688.ref053
  doi: 10.1126/science.abc5798
– volume: 93
  year: 2019
  ident: pcbi.1008688.ref048
  article-title: Fighting homelessness and housing exclusion in Europe
  publication-title: A Study of National Policies, European Social Policy Network (ESPN)
  contributor:
    fullname: I Baptista
– year: 2020
  ident: pcbi.1008688.ref042
  article-title: False Negative Tests for SARS-CoV-2 Infection—Challenges and Implications
  publication-title: New England Journal of Medicine
  contributor:
    fullname: S Woloshin
SSID ssj0035896
Score 2.5169604
Snippet Outbreaks of SARS-CoV-2 are threatening the health care systems of several countries around the world. The initial control of SARS-CoV-2 epidemics relied on...
[...]our model shows that the use of universal testing in combination with stringent contact reductions could be considered as a strategy to eradicate the...
SourceID plos
doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e1008688
SubjectTerms Belgium
Belgium - epidemiology
Biology and life sciences
Compliance
Computational Biology
Computer Simulation
Contact tracing
Contact Tracing - methods
Contact Tracing - statistics & numerical data
Contact Tracing - trends
Control
Coronaviruses
COVID-19
COVID-19 - epidemiology
COVID-19 - prevention & control
COVID-19 - transmission
COVID-19 Nucleic Acid Testing - methods
COVID-19 Nucleic Acid Testing - statistics & numerical data
COVID-19 Nucleic Acid Testing - trends
Disease transmission
Epidemics
Epidemics - prevention & control
False Negative Reactions
Family Characteristics
Feasibility
Feasibility Studies
Households
Humans
Immune system
Infections
Mass Screening - methods
Mass Screening - statistics & numerical data
Mass Screening - trends
Medicine and Health Sciences
Model testing
Models, Statistical
Pandemics
People and places
Population
Quarantine - methods
Quarantine - statistics & numerical data
Quarantine - trends
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Social distancing
Social Sciences
Telecommuting
Test procedures
Testing
Travel
Viruses
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELXQSkhcEN8NLMggJE6m69hJ7GMpVC0SRQKK9mb5K20llKzI7qH_npnYuzSoiAvXeOSNZyb28_r5DSGvXa3rNljNbKMck8IF5oLizDtdudgCKA_4P-Sn0_r4TH5cVstrpb6QE5bkgZPj9rkOsGb7qG3QklsFe-RWBeFlpbwObbrmu9DbzVSag0WlxspcWBSHNUIu86U50fD9HKO3K-8ukSOgUtWV34vSqN2_m6Fnqx_9cBP8_JNFeW1ZOrpH7mY8SQ_SOO6TW7F7QG6nCpNXD0mfDnVhfaKA9GgbbabDXlHbBZrYHHnCo31LL_rNEPFEimHtrRjoJhE34CfWqMeB_fQ089vp4efvJ-8Z1zSmOrN-eETOjj58OzxmucYC87Ayr5lwPDZlG0vpnCuxHtki8rDAspJttfAW9dmDs6KBYNfgbxE4zAJl5G1lvXCleExmXd_FPUKdV1LXsfSVrWTpudWeN3WUgPGcjqUuCNs62aySlIYZz9Ma2IIkbxkMislBKcg7jMTOFoWwxweQHianh_lXehTkFcbRoNRFh1yac7sZBnPy9dQcAPhqOAAU-VejLxOjN9mo7SHe3ub7CzB4lNCaWM4nlvDB-knzHubUdsyDAYgpagVICt52vs2zm5tf7pqxU-THdRESA2zwiFdxyQvyJKXlzm9CjGLUdUGaScJOHDtt6S4vRqVxVA-Ejp_-j0g8I3dK5AMhf0_PyWz9cxOfA6Bbuxfjt_sL2CZJTA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgERIXxLvbFmQQEifTdezE9gmVwtIiUSSgaG-RX2krVcnS7B7675lJnC1Bhet64k0845mJ58t8hLx2hSmqYA2zSjsmhQvMBc2ZdyZ3sYKkPOA55Jfj4vBEfl7ki3Tg1iZY5eATO0cdGo9n5HsQh0WhIdzod8tfDFmjsLqaKDRukzs8UwpfvvT80-CJRa47fi6kxmFKyEX6dE4ovpc09Xbp3TkiBXTPvXIdmroO_hs_PVleNO1NSejfWMo_gtP8Abmfskq635vBQ3Ir1o_I3Z5n8uoxafrSLkQpCvkeraJNoNgrautAe0xHcnu0qehZs24j1qUYMnDFQNc9fAP-YoVdOXCehiaUOz34-vPoA-OGxp5t1rdPyMn844-DQ5aYFpiH-LxiwvGosipm0jmXISvZLPIwQ3LJKp95i13ag7NCgcoLEyoROPiCLPIqt164TDwlk7qp4xahzmtpipj53OYy89waz1URJWR6zsTMTAkbFrlc9g01yq6qpuBFpF-tEpVSJqVMyXvUxEYW22F3PzSXp2XaXSU3ARI7H40NRnKrjVaVDsLLXHu4XZjkFeqxxIYXNSJqTu26bcuj78flPqRgikOaIv8p9G0k9CYJVQ3o29v0FQM8PDbSGknujiRh2_rR8Bba1PDMbXlt4HDlYGc3D7_cDOOkiJKrIxgGyGChV3PJp-RZb5abdROia0ldTIkaGexoYccj9flZ128cewjCxNv_v60dci9DvA_i88wumawu1_E5JGwr96Lblb8B8HdAbw
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9RAFB7qiuCLeO_qKqMIPqXsXJLMPIjUamkFK6grfQtzS1soybrZBfffe04yCUa24OvOySSZc2bmmz1fvkPIG5vprPRGJyZXNpHC-sR6xRJndWpDCaDc4_-QX86yk4X8fJ6e75G-ZmscwGbn0Q7rSS1W1we_f23fw4R_11ZtyFl_0cHS2SvM-qtMqVvkNpdwVkcynxzyCiJVOosf0N105WiDanX8h9V6sryum11Q9F9G5V9b1PF9ci9iS3rYBcMDsheqh-ROV21y-4jUXYIX9ioKqI-WwURq7JaaytOO2REXP1qX9LLeNAGzUwnW4QqebjoSB9xijdoc2E9NI9edHn39efoxYZqGruasax6TxfGnH0cnSay3kDjYpdeJsCzkvAxcWms51iabB-bnWGKyTOfOoFa7t0bk4PhM-1J4BisCD6xMjROWiydkUtVV2CfUOiV1FrhLTSq5Y0Y7lmdBAt6zOnA9JUk_yMWyk9Uo2txaDseRbrQKdEoRnTIlH9ATgy2KYrc_1KuLIs6xgmkP8M4FbbyWzCit8lJ54WSqHDwudPIa_Vig7EWFvJoLs2ma4vT7WXEIQCxnAFbkjUbfRkZvo1FZg7-did8ywMujnNbIcjayhMnrRs37GFP9OzcFwE2RKUBV8LSzPs52N78amrFT5MpVAQIDbDDdq5hkU_K0C8th3IRohamzKclHATsa2HFLdXXZqo6jkiB0_Ow_7vuc3OVI_UGqnp6RyXq1CS8Au63ty3Y6_gFZmEYv
  priority: 102
  providerName: Scholars Portal
Title Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics
URI https://www.ncbi.nlm.nih.gov/pubmed/33690626
https://www.proquest.com/docview/2513684158
https://search.proquest.com/docview/2500388141
https://pubmed.ncbi.nlm.nih.gov/PMC7943003
https://doaj.org/article/19d264ce9ad941a8987f8d3c458c9df8
http://dx.doi.org/10.1371/journal.pcbi.1008688
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2IiReJr5XKJVBSDylneN82I9tt7IhtUyDob5F_so2aUuqpX3Yf89d4lQEjRdeEqm-Oo7vzv7FPv-OkM86kUlulQxUKnQQcW0DbQULjJaxdjmAcovrkItlcnoZfVvFqz0St2dh6qB9o29Gxe3dqLi5rmMr13dm3MaJjc8XMyQ1wwW4fbIPBtp-ojfDL49FnZQL8-EEKY9W_rwcT9nYq2e0xgcgq00iMF8f5zVbb9KZmmoG_9043VvfltVjIPTvWMo_Jqf5c3LgUSWdNK1_QfZc8ZI8bfJMPrwiZbO1C7MUBbxHc6d8UOwDVYWlTUyHH_ZomdPrcls53JcKMAOXs3TbhG_AIzbIyoH1lNRHudPZ919nxwGT1DXZZk31mlzOT37OTgOfaSEwMD9vAq6ZS8PchZHWOsSsZEeO2SNMLpnHR0YhS7vViqeg8kTanFsGY0HoWB4rw3XI35BeURbukFBtRCQTF5pYxVFomJKGpYmLAOlp6ULZJ0Hbydm6IdTI6l21FD5Emt7KUD-Z10-fTFETO1mkw65_KO-vMm8UGZMWgJ1xUlkZMSWkSHNhuYliYaC5UMkn1GOGhBcFRtRcqW1VZWc_ltkEIFjKAKZE_xS66Ah98UJ5Cfo2yp9igJdHIq2O5KAjCW5rOsWHaFPtO1cZAE2eCMBT0NpBa2ePF3_cFWOlGCVXODAMkMGNXsEi1idvG7Pc9Vtr5H2Sdgy207HdEnC_mm_cu9u7__7ne_IsxFMjmEcnGZDe5n7rPgCW2-ghePAqhauYfx2SJ5Pp8XQO9-nJ8vwC7rUBD-t1ErguIjGsff03MvJRkg
link.rule.ids 230,315,730,783,787,867,888,2109,2228,12068,12777,21400,24330,27936,27937,31731,31732,33385,33386,33756,33757,38528,43322,43612,43817,43907,53804,53806,74073,74363,74630,74740
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegCMHLxPc6BhiExJNZHTuJ_YTGoLSwFQk21LfIX9kmoaQs7cP-e-4StyNo8Fpf3cR3vrv6fr4fIa9tprPSG81MriyTwnpmveLMWZ3aUEJS7vEc8miWTU7k53k6jwduTYRVrn1i66h97fCMfA_isMgUhBv1bvGLIWsUVlcjhcZNcksKiNV4U3z8ae2JRapafi6kxmG5kPN4dU7kfC9q6u3C2XNECqiOe-UqNLUd_Dd-erD4WTfXJaF_Yyn_CE7je2QrZpV0vzOD--RGqB6Q2x3P5OVDUnelXYhSFPI9WgYTQbGX1FSedpiO6PZoXdKzetUErEsxZOAKnq46-Ab8xBK7cuA8NY0od3rw9cf0A-Oaho5t1jWPyMn44_HBhEWmBeYgPi-ZsDzkSRkSaa1NkJVsFLgfIblkmY6cwS7t3hqRg8oz7UvhOfiCJPAyNU7YRDwmg6quwjah1imps5C41KQycdxox_MsSMj0rA6JHhK2XuRi0TXUKNqqWg5_RLrVKlApRVTKkLxHTWxksR12-0F9cVrE3VVw7SGxc0EbryU3Squ8VF44mSoHjwuTvEI9FtjwokJEzalZNU0x_T4r9iEFyzmkKfKfQt96Qm-iUFmDvp2Jtxjg5bGRVk9ytycJ29b1hrfRptbv3BRXBg7fXNvZ9cMvN8M4KaLkqgCGATJY6FVc8iF50pnlZt2EaFtSZ0OS9wy2t7D9ker8rO03jj0EYeKd_z_WC3Jncnx0WBxOZ1-ekrsJYn8Qq6d3yWB5sQrPIHlb2uftDv0N-nFDUQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1db9MwFLWgE4gXvmGFAQYh8ZS2jp3EfkJjY1r5KAgY6lvkr2zTUFKW9mH8eu5NnI5Mgyde61s3sa-vT-OTcwh5aVKVFk6rSGfSRIIbFxknWWSNSowvAJQ7fA75cZbuH4h382Qe-E91oFV2NbEp1K6y-Ix8DPswTyVsN3JcBFrE592914ufETpI4UlrsNO4SjYAIovJgGzsfPo-3e3qMk9k49aFRjlRxsU8vEjHMzYO8zZaWHOMvAHZOrGcb1SNnv-6ag8WP6r6Mkh6kVn5x1a1d4ucdDfZMlRORqulGdlfF_Qf_88o3CY3A6Kl220K3iFXfHmXXGs9Ls_ukao9VoYdkgLWpIXXgZB7RnXpaMsnCSWXVgU9qla1xzOxCN2_vKOrljoCP7FERRDsp6KBYU-bsY-Yor51urX1fXKw9_bbzn4UXB4iC9hgGXHDfBYXPhbGmBgd0SaeuQkaWxbJxGpUiHdG8wzSLVWu4I5BHYo9KxJtuYn5AzIoq9JvEmqsFCr1sU10ImLLtLIsS70AlGmUj9WQRN2U5otWzCNvTvQy-BPUjlaOKZCHFBiSNzjv61iU4m4-qE4P87Cyc6YcgErrlXZKMC2VzArpuBWJtHC50MkLzJocxTZKnLBDvarrfPp1lm8D_MsYQCTx16AvvaBXIaioILusDm9QwM2jiFcvcqsXCSXD9po3MYO7e67z87SCb3aJd3nz83UzdooMvdJDYkAMHjJLJtiQPGwXwXrcOG_ksNMhyXrLozew_Zby-KjROkf9Quj40b8v6xm5Dssg_zCdvX9MbsRIO0KaoNoig-Xpyj8B3Lg0T0NB-A29BXBg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessing+the+feasibility+and+effectiveness+of+household-pooled+universal+testing+to+control+COVID-19+epidemics&rft.jtitle=PLoS+computational+biology&rft.au=Libin%2C+Pieter+J+K&rft.au=Willem%2C+Lander&rft.au=Verstraeten%2C+Timothy&rft.au=Torneri%2C+Andrea&rft.date=2021-03-09&rft.eissn=1553-7358&rft.volume=17&rft.issue=3&rft.spage=e1008688&rft.epage=e1008688&rft_id=info:doi/10.1371%2Fjournal.pcbi.1008688&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1553-7358&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1553-7358&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1553-7358&client=summon